汉森制药：公司取得换发的药品生产许可证

Core Points - Company obtained a new drug production license from Hunan Provincial Drug Administration, ensuring continued operations until November 6, 2030 [1] - The new license covers a wide range of products including large volume injections, small volume injections, tablets, hard capsules, granules, syrups, tinctures, mixtures, pills, and second-class psychotropic drugs [1] - The renewal of the license is based on the expiration of the previous one and does not have a significant impact on the company's performance [1]